These results collectively highlight the strong suppressive impact of HSPB6 elevation on the migration and invasion activities of bladder cancer cells, pointing to its potential value as a therapeutic target in halting the progression of bladder cancer. This evidence concerns the gene HSPB6 and urinary bladder cancer.